Results 201 to 210 of about 28,831 (253)

Is DCIS Overrated?

2018
Ductal carcinoma in situ (DCIS), the noninvasive form of breast cancer (BC), comprises just over 20% of breast cancer cases diagnosed each year in the USA. Most patients are treated with local excision of the disease followed by whole breast radiation therapy.
Joshua, Feinberg, Rachel, Wetstone, Dana, Greenstein, Patrick, Borgen   +3 more
openaire   +2 more sources

Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component

Annals of Surgical Oncology, 2010
Breast ductal carcinoma in situ with microinvasion (DCIS-Mi) is considered to be the interim stage in the progression from DCIS to invasive breast cancer (IDC). Cases that exceed DCIS-Mi but still do not fulfill the diagnostic criteria of IDC often are observed.
Ke-Da, Yu, La-Mu, Wu, Guang-Yu, Liu, Jiong, Wu, Gen-Hong, Di, Zhen-Zhou, Shen, Zhi-Ming, Shao   +6 more
openaire   +2 more sources

The Impact of MRI on the Treatment of DCIS

The American Surgeon™, 2005
Magnetic resonance imaging (MRI) has been shown to detect occult invasive breast cancers with a sensitivity of 97 per cent to 100 per cent. Mammography and ultrasonography does not accurately assess the extent of ductal carcinoma in situ (DCIS), which results in a high reoperation rate.
Alice, Chung, Rola, Saouaf, Karen, Scharre, Edward, Phillips   +3 more
openaire   +2 more sources

Current management of DCIS: a review

Breast Cancer Research and Treatment, 2007
Ductal carcinoma in-situ (DCIS) is a heterogeneous disease, in terms of its radiological characteristics, histological morphology and molecular attributes. This diversity is reflected in its natural history and influences optimal treatment strategy. A significant proportion of DCIS lesions behave in a clinically benign fashion and do not progress to ...
Neill, Patani, Bruno, Cutuli, Kefah, Mokbel   +2 more
openaire   +2 more sources

Zbrinjavanje DCIS

2023
U predavanju je obuhvaćeno povijesno i sadašnje zbrinjavanje duktalnog karcinoma in situ, prikazani su rezultati Klinike za tumore u liječenju DCIS, uključujući učestalost recidiva nakon 10-15 godina. Također, prikazani su trendovi budućeg liječenja ove bolesti, kao i prospektivne studije koje su u tijeku, a istražuju aktivno praćenje DCIS ...
Stanec, Mladen, Milas, Ivan, Guteša, Ilija   +2 more
openaire  

The defence for the U.K. DCIS trial

European Journal of Cancer, 1993
INTRODUCTION THE U.K. ductal carcinoma in siru (DCIS) trial started in May 1991, after a gestation period of 36 months, having been designed by a multidisciplinary committee. This comprised clinicians with a particular interest in DCIS and included surgeons, radiotherapists, pathologists, statisticians and data centre coordinators. The aim of the study
I S, Fentiman, C A, Joslin
openaire   +2 more sources

The Van Nuys DCIS Prognostic Index →The Silverstein DCIS Prognostic Index

Annals of Surgical Oncology
After 60 years of surgical service and the creation/development of three breast centers at the Van Nuys Breast Center, the University of Southern California (USC), and the Hoag Family Cancer Institute, Dr. Melvin J. Silverstein has announced his retirement. Dr.
Gary A, Ulaner, Sadia, Khan, Nirav B, Savalia, January, Lopez   +3 more
openaire   +2 more sources

DCIS: Pathology and Molecular Markers

2006
Ductal carcinoma in situ (DCIS) represents a proliferation of malignant epithelial cells within the ducts of the breast, without invasion through the basement membrane. It is assumed that all invasive carcinomas of the breast are preceded by DCIS; however, it is not known what proportion of DCIS, if left untreated, will progress to invasive carcinoma ...
Meijnen, Philip, Peterse, Johannes L., Van De Vijver, Marc J.   +2 more
openaire   +2 more sources

Importance of Lymphatic Mapping in Ductal Carcinoma in Situ (DCIS): Why Map DCIS?

The American Surgeon, 2001
The appropriateness of sentinel lymph node biopsy in the management of patients with biopsy diagnoses of ductal carcinoma in situ (DCIS) or DCIS with microinvasion (DCISM) has not been established. Three hundred forty-one patients presented with a biopsy diagnosis of DCIS or DCISM.
C E, Cox, K, Nguyen, R J, Gray, C, Salud, N N, Ku, E, Dupont, L, Hutson, E, Peltz, G, Whitehead, D, Reintgen, A, Cantor   +10 more
openaire   +2 more sources

Space Charge Compensation with DCI

1980
Extensive tests of space charge compensation, at the energy of.8 GeV, in similar conditions to those of the e+e− configuration are reported. Stability regions, smaller in size than those observed in that configuration, are found to decrease rapidly with current. Up to the limit, the beam cross-section stays constant.
Le Duff, J., Level, M.P., Marin, P.C., Sommer, E.M., Zyngier, H.   +4 more
openaire   +2 more sources